Apollo Endosurgery (NASDAQ:APEN – Get Rating) and Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation. Analyst Ratings This is a breakdown of current ratings […]
Shares of Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $8.19 and traded as high as $9.93. Apollo Endosurgery shares last traded at $9.89, with a volume of 821,386 shares trading hands. Analyst Ratings Changes A number […]
Apollo Endosurgery (NASDAQ:APEN – Get Rating) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.01), MarketWatch Earnings reports. Apollo Endosurgery had a negative return on equity of 148.35% and a negative net margin of 39.19%. During the same […]
Wall Street brokerages forecast that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will post ($0.21) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Apollo Endosurgery’s earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.16). Apollo Endosurgery reported earnings per share of […]
Equities analysts predict that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will report $15.69 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Apollo Endosurgery’s earnings, with the highest sales estimate coming in at $15.90 million and the lowest estimate coming in at $15.49 million. Apollo […]